RxDoctor Payments Data

Elizabeth Hensley, MD

Family Medicine · South Charleston, WVNPI 1578526943

Payments from drug & device makers

$4,623in general payments, 2019–2025

Across 264 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$780
  • Novo Nordisk$692
  • Lilly USA, LLC$652
  • AbbVie$574
  • Sanofi-aventis U.S. LLC$314
  • Boehringer Ingelheim$274
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$4,617100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,623 in reported general payments places this provider in the 85th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$77,883
Medicare patients
193
Services billed
728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide87$124,184
OzempicSemaglutide93$110,283
JardianceEmpagliflozin68$87,552
Soliqua 100-33Insulin Glargine/Lixisenatide58$58,123
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog36$41,072
JanuviaSitagliptin Phosphate21$30,769
TrulicityDulaglutide14$30,428
EliquisApixaban22$20,303
UnithroidLevothyroxine Sodium89$11,621
VascepaIcosapent Ethyl15$11,014
SynthroidLevothyroxine Sodium110$8,116
Novolog FlexpenInsulin Aspart19$6,545
SymbicortBudesonide/Formoterol Fumarate17$6,066
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$5,091
LyricaPregabalin11$3,794

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$652$154,612101 claims
Novo NordiskOzempic$692$110,28393 claims
Boehringer IngelheimJardiance$274$87,55268 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$314$58,12358 claims
MerckJanuvia$216$30,76921 claims
Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium$104$15,068472 claims
AbbVieSynthroid$574$8,116110 claims
AstraZenecaSymbicort$780$6,06617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 843 family medicine providers in West Virginia.

Other family medicine in South Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →